1999
Started as India’s first independent product development company
2007
Received investment from Kotak India Venture Fund – I, Kotak India Venture Limited and Kotak Employees Investment Trust.
2009
Commissioned oral solids manufacturing facility in Ambernath, India
2010
First ANDA filing
2011
Commencement of manufacturing of certain special drugs in Ambernath Manufacturing Facility.
Receipt of certificate of GMP compliance for Ambernath Manufacturing Facility for tablet manufacturing and secondary packaging by Medicines and Healthcare Products Regulatory Agency, United Kingdom.
2013
Receipt of GMP clearance approval for Ambernath Manufacturing Facility from Department of Health and Ageing Therapeutic Goods Administration, Australian Government.
2014
Receipt of approval for our product i.e., ‘metoprolol tartrate tablets’ from the Food & Drug Administration, United State of America.
2016
Acquisition of majority stake by ECP III Pte Ltd.
2017
Receipt of certificate of GMP compliance for Ambernath Manufacturing Facility from the Ministerio De Sandidad, Servicios Sociales E Igualdad, Spain.
2019
Acquisition of majority stake by General Atlantic Singapore RR Pte. Ltd., from ECP III Pte. Ltd.
Acquisition of Impopharma Canada Limited by Rubicon Research Canada Limited 2021 Acquired the business of Meditab Specialities Limited on a slump sale basis.
2020
Launch of Rubicon Consumer Healthcare
Launch of Rubicon Academy
2021
Acquired an oral liquid and nasal product manufacturing facility in Satara, Maharashtra
2022
Set up own sales and marketing front end in US via our Material Subsidiary.
2023
Receipt of certificate of GMP compliance for Satara Manufacturing Facility .of non-sterile liquid drug manufacturer and pre-approval coverage provided for non-sterile liquid product by US FDA.
2024
Acquisition of Validus Pharmaceuticals LLC.
ANDA pre-approval drug inspection of nasal spray block at Ambernath Manufacturing Facility by USFDA.
Receipt of supplement approval for our Thane R&D Facility as a testing site of drug substancelead test from USFDA.